Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets ![]() |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 85,363,057 | $8,536,305,730.00 | 6.64% |
Pfizer, Inc. | Equity | 58,264,900 | $3,016,373,873.00 | 2.35% |
Philip Morris International, Inc. | Equity | 30,586,706 | $2,873,315,162.00 | 2.23% |
Broadcom, Inc. | Equity | 4,526,138 | $2,850,018,576.00 | 2.22% |
Microsoft Corp. | Equity | 7,343,200 | $2,263,981,992.00 | 1.76% |
CME Group, Inc., Class A | Equity | 9,373,078 | $2,229,480,333.00 | 1.73% |
Lockheed Martin Corp. | Equity | 5,023,242 | $2,217,259,019.00 | 1.72% |
Crown Castle International Corp. REIT | Equity | 8,939,236 | $1,650,182,966.00 | 1.28% |
JPMorgan Chase & Co. | Equity | 11,954,374 | $1,629,620,264.00 | 1.27% |
AstraZeneca PLC | Equity | 12,242,600 | $1,623,506,006.00 | 1.26% |
Altria Group, Inc. | Equity | 28,790,000 | $1,504,277,500.00 | 1.17% |
General Mills, Inc. | Equity | 22,296,277 | $1,509,903,878.00 | 1.17% |
Taiwan Semiconductor Manufacturing Company, Ltd. | Equity | 70,975,300 | $1,467,374,164.00 | 1.14% |
Chevron Corp. | Equity | 8,688,486 | $1,414,746,175.00 | 1.1% |
Gilead Sciences, Inc. | Equity | 22,828,778 | $1,357,170,852.00 | 1.06% |